307 related articles for article (PubMed ID: 27535837)
1. Multivalent and Multipathogen Viral Vector Vaccines.
Lauer KB; Borrow R; Blanchard TJ
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27535837
[TBL] [Abstract][Full Text] [Related]
2. Applications and challenges of multivalent recombinant vaccines.
Naim HY
Hum Vaccin Immunother; 2013 Mar; 9(3):457-61. PubMed ID: 23249651
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
4. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
Hutchings CL; Birkett AJ; Moore AC; Hill AV
Infect Immun; 2007 Dec; 75(12):5819-26. PubMed ID: 17908809
[TBL] [Abstract][Full Text] [Related]
5. Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
Ramezanpour B; Haan I; Osterhaus A; Claassen E
Vaccine; 2016 Dec; 34(50):6436-6448. PubMed ID: 28029542
[TBL] [Abstract][Full Text] [Related]
6. Recent advancements in combination subunit vaccine development.
Tan M; Jiang X
Hum Vaccin Immunother; 2017 Jan; 13(1):180-185. PubMed ID: 27649319
[TBL] [Abstract][Full Text] [Related]
7. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
Taylor J; Paoletti E
Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
[TBL] [Abstract][Full Text] [Related]
8. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
An LL; Whitton JL
J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
[TBL] [Abstract][Full Text] [Related]
9. New viral vectors for infectious diseases and cancer.
Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
[TBL] [Abstract][Full Text] [Related]
11. Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya.
Gerke C; Frantz PN; Ramsauer K; Tangy F
Expert Rev Vaccines; 2019 Apr; 18(4):393-403. PubMed ID: 30601074
[TBL] [Abstract][Full Text] [Related]
12. Vaccine platform recombinant measles virus.
Mühlebach MD
Virus Genes; 2017 Oct; 53(5):733-740. PubMed ID: 28710608
[TBL] [Abstract][Full Text] [Related]
13. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801
[TBL] [Abstract][Full Text] [Related]
14. Recombinant vaccines and the development of new vaccine strategies.
Nascimento IP; Leite LC
Braz J Med Biol Res; 2012 Dec; 45(12):1102-11. PubMed ID: 22948379
[TBL] [Abstract][Full Text] [Related]
15. Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen.
Flexner C; Murphy BR; Rooney JF; Wohlenberg C; Yuferov V; Notkins AL; Moss B
Nature; 1988 Sep; 335(6187):259-62. PubMed ID: 2842693
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice.
Li E; Yan F; Huang P; Chi H; Xu S; Li G; Liu C; Feng N; Wang H; Zhao Y; Yang S; Xia X
Viruses; 2020 Jan; 12(1):. PubMed ID: 31968702
[TBL] [Abstract][Full Text] [Related]
17. Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector.
Knuchel MC; Marty RR; Morin TN; Ilter O; Zuniga A; Naim HY
Hum Vaccin Immunother; 2013 Mar; 9(3):599-606. PubMed ID: 23324399
[TBL] [Abstract][Full Text] [Related]
18. Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses.
Billeter MA; Naim HY; Udem SA
Curr Top Microbiol Immunol; 2009; 329():129-62. PubMed ID: 19198565
[TBL] [Abstract][Full Text] [Related]
19. Multivalent DNA Vaccines as A Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses.
Jiang J; Ramos SJ; Bangalore P; Elwood D; Cashman KA; Kudchodkar SB; Schultheis K; Pugh H; Walters J; Tur J; Yan J; Patel A; Muthumani K; Schmaljohn CS; Weiner DB; Humeau LM; Broderick KE
Viruses; 2021 Feb; 13(3):. PubMed ID: 33673603
[TBL] [Abstract][Full Text] [Related]
20. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
